Copyright
©The Author(s) 2017.
World J Gastroenterol. May 7, 2017; 23(17): 3150-3162
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3150
Published online May 7, 2017. doi: 10.3748/wjg.v23.i17.3150
Parameter | mean ± SD, BL | mean ± SD, 3M | mean ± SD, 6M | P value | ||
BL vs 3M | 3M vs 6M | BL vs 6M | ||||
BMI (kg/m2) | 29.3 ± 6.11 | 28.0 ± 6.21 | 27.5 ± 6.21 | < 0.01a | < 0.01a | < 0.01a |
Waist circumference (cm) | 101.25 ± 13.63 | 97.50 ± 14.07 | 96.24 ± 13.64 | < 0.01a | < 0.01a | < 0.01a |
Hip-to-waist ratio | 0.95 ± 0.08 | 0.94 ± 0.07 | 0.93 ± 0.08 | < 0.01a | < 0.01a | < 0.01a |
AST (U/L) | 36.16 ± 21.11 | 28.73 ± 11.28 | 24.84 ± 10.70 | < 0.01a | < 0.01a | < 0.01a |
ALT (U/L) | 65.66 ± 31.92 | 48.37 ± 33.44 | 37.33 ± 19.53 | < 0.01a | < 0.01a | < 0.01a |
GGT (U/L) | 60.19 ± 61.43 | 41.35 ± 36.49 | 39.73 ± 35.36 | < 0.01a | 0.545 | < 0.01a |
FA (U/L) | 81.48 ± 37.19 | 79.54 ± 32.04 | 80.04 ± 35.02 | 0.489 | 0.787 | 0.574 |
Total cholesterol (mg/dL) | 215.24 ± 40.78 | 205.04 ± 41.75 | 207.18 ± 38.48 | 0.044a | 0.598 | 0.097 |
LDL cholesterol (mg/dL) | 137.70 ± 32.87 | 131.25 ± 35.88 | 130.16 ± 32.65 | 0.071 | 0.941 | 0.050a |
HDL cholesterol (mg/dL) | 49.72 ± 10.59 | 50.17 ± 11.64 | 53.09 ± 11.86 | 0.550 | < 0.01a | < 0.01a |
TG (mg/dL) | 133.39 ± 67.77 | 123.65 ± 71.31 | 118.24 ± 65.14 | 0.112 | 0.358 | 0.017a |
Serum glucose (mg/dL) | 98.33 ± 15.87 | 94.52 ± 13.07 | 95.76 ± 13.46 | < 0.01a | 0.133 | < 0.01a |
Chol Tot/HDL | 4.50 ± 1.27 | 4.23 ± 1.07 | 3.95 ± 1.15 | 0.013a | 0.010a | < 0.01a |
LDL/HDL | 2.89 ± 0.95 | 2.67 ± 0.93 | 2.56 ± 0.84 | 0.028a | 0.015a | < 0.01a |
TG/HDL | 2.87 ± 1.76 | 2.66 ± 1.89 | 2.39 ± 1.66 | 0.152 | 0.037a | < 0.01a |
AIP | 0.03 ± 0.25 | -0.01 ± 0.23 | -0.06 ± 0.25 | 0.097 | 0.089 | < 0.01a |
HOMA- IR (mU/L) | 3.25 ± 1.96 | 2.96 ± 1.73 | 2.94 ± 1.67 | < 0.01a | 0.841 | < 0.01a |
QUICKI | 0.33 ± 0.04 | 0.34 ± 0.04 | 0.34 ± 0.03 | < 0.01a | 0.330 | < 0.017a |
PLR | 115.37 ± 46.60 | 109.89 ± 51.77 | 113.65 ± 43.77 | 0.195 | 0.281 | 0.816 |
NLR | 1.98 ± 1.12 | 1.88 ± 1.10 | 1.79 ± 0.89 | 0.287 | 0.509 | 0.185 |
FLI | 61.55 ± 26.76 | 50.54 ± 29.37 | 48.83 ± 31.01 | < 0.01a | 0.286 | < 0.01a |
Kotronen index (%) | 6.05 ± 5.02 | 4.10 ± 2.22 | 3.92 ± 2.40 | < 0.01a | 0.277 | < 0.01a |
VAI | 1.85 ± 1.17 | 1.55 ± 0.71 | 1.32 ± 0.65 | 0.011 | 0.010 | < 0.01a |
NAFLD Liver Fat Score | 0.12 ± 1.63 | -0.02 ± 1.42 | -0.70 ± 1.20 | 0.418 | < 0.01a | < 0.01a |
LAP (male) | 48.41 ± 28.14 | 37.01 ± 19.95 | 33.18 ± 17.49 | < 0.01a | 0.166 | < 0.01a |
LAP (female) | 84.15 ± 63.06 | 78.92 ± 70.51 | 74.13 ± 58.89 | 0.290 | 0.452 | < 0.01a |
BARD | 1.09 ± 1.26 | 1.46 ± 1.17 | 1.37 ± 1.04 | 0.011a | 0.486 | 0.091 |
NAFLD | -2.29 ± 0.93 | -2.13 ± 1.01 | -2.28 ± 1.00 | 0.015a | 0.032a | 0.986 |
- Citation: Gelli C, Tarocchi M, Abenavoli L, Di Renzo L, Galli A, De Lorenzo A. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(17): 3150-3162
- URL: https://www.wjgnet.com/1007-9327/full/v23/i17/3150.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i17.3150